Showing 4901-4920 of 7110 for: Cochrane Systematic Reviews Back
- Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy
Cochrane Systematic Reviews, 21-Sep-2012
Chagas disease-related cardiomyopathy is a major cause of morbidity and mortality in Latin America. Despite the substantial burden to the healthcare system, there is uncertainty regarding the efficacy and safety of pharmacological interventions for treati
- Pharmacological interventions for unilateral spatial neglect after stroke
Cochrane Systematic Reviews, 5-Nov-2015
Unilateral spatial neglect (USN) is characterized by the inability to report or respond to people or objects presented on the side contralateral to the lesioned side of the brain and has been associated with poor functional outcomes and long stays in hosp
- Pharmacological interventions other than botulinum toxin for spasticity after stroke
Cochrane Systematic Reviews, 6-Oct-2016
The long-term risk of stroke increases with age, and stroke is a common cause of disability in the community. Spasticity is considered a significantly disabling impairment that develops in people who have had a stroke. The burden of care is higher in stro
- Pharmacological interventions to decrease blood loss and blood transfusion requirements for liver resection
Cochrane Systematic Reviews, 13-Aug-2009
Blood loss during liver resection is one of the most important factors affecting the peri-operative outcomes of patients undergoing liver resection.
- Pharmacological interventions versus no pharmacological intervention for ischaemia reperfusion injury in liver resection surgery performed under vascular control
Cochrane Systematic Reviews, 11-Aug-2009
Vascular occlusion to reduce blood loss is used during elective liver resection but results in significant ischaemia reperfusion injury. This, in turn, might lead to significant postoperative liver dysfunction and morbidity. Various pharmacological drugs
- Pharmacological management for agitation and aggression in people with acquired brain injury
Cochrane Systematic Reviews, 13-May-2008
Of the many psychiatric symptoms that may result from brain injury, agitation and/or aggression are often the most troublesome. It is therefore important to evaluate the efficacy of psychotropic medication used in its management.
- Pharmacological therapies for maintenance treatments of opium dependence
Cochrane Systematic Reviews, 29-Nov-2012
Pharmacologic therapies for maintenance treatment of heroin dependence have been used and studied widely. Systematic reviews have demonstrated the effectiveness of such therapies. Opium dependence is associated with less problems and impairments and is le
- Pharmacological treatment for aphasia following stroke
Cochrane Systematic Reviews, 23-Mar-2010
Aphasia describes language impairment associated with a brain lesion.
- Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders
Cochrane Systematic Reviews, 10-Mar-2011
Attention Deficit Hyperactivity Disorder (ADHD) is the most prevalent of the comorbid psychiatric disorders that complicate tic disorders. Medications commonly used to treat ADHD symptoms include the stimulants methylphenidate and amphetamine; nonstimulan
- Pharmacological treatment for Buerger's disease
Cochrane Systematic Reviews, 11-Mar-2016
Buerger's disease (thromboangiitis obliterans) is a non-atherosclerotic, segmental inflammatory pathology that most commonly affects the small and medium sized arteries, veins, and nerves in the upper and lower extremities. The etiology is unknown, but in
- Pharmacological treatment for depression during opioid agonist treatment for opioid dependence
Cochrane Systematic Reviews, 22-Jul-2010
Lifetime prevalence of depression in subjects with opioid dependence is higher than in the general population (44-54% versus 16%) and represents a risk factor for morbidity and mortality. For patients on opioid agonist treatment, current prevalence rates
- Pharmacological treatment for Kleine-Levin syndrome
Cochrane Systematic Reviews, 7-Aug-2013
This is an updated version of the original Cochrane review, published in Issue 2, 2009.
- Pharmacological treatment for memory disorder in multiple sclerosis
Cochrane Systematic Reviews, 16-Dec-2013
This is an update of the Cochrane review "Pharmacologic treatment for memory disorder in multiple sclerosis" (first published in The Cochrane Library 2011, Issue 10).
- Pharmacological treatment for pain in Guillain-Barré syndrome
Cochrane Systematic Reviews, 8-Apr-2015
Pain in Guillain-Barré syndrome (GBS) is common, yet it is often under recognised and poorly managed. In recent years, a variety of pharmacological treatment options have been investigated in clinical trials for people with GBS-associated pain. This is an
- Pharmacological treatment for psychotic depression
Cochrane Systematic Reviews, 16-Jul-2015
Evidence is limited regarding the most effective pharmacological treatment for psychotic depression: combination of an antidepressant plus an antipsychotic, monotherapy with an antidepressant or monotherapy with an antipsychotic. This is an update of a re
- Pharmacological treatment of children with gastro-oesophageal reflux
Cochrane Systematic Reviews, 24-Nov-2014
Gastro-oesophageal reflux (GOR) is a common disorder, characterised by regurgitation of gastric contents into the oesophagus. GOR is a very common presentation in infancy in both primary and secondary care settings. GOR can affect approximately 50% of inf
- Pharmacological treatment of depression in patients with a primary brain tumour
Cochrane Systematic Reviews, 11-Feb-2015
This is an updated version of the original Cochrane review published in Issue 3, 2010.
- Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysm
Cochrane Systematic Reviews, 21-Jan-2014
Pharmacological prophylaxis has been proven to reduce the risk of cardiovascular events in patients with atherosclerotic occlusive arterial disease. However, the role of prophylaxis in patients with abdominal aortic aneurysm (AAA) remains unclear. Several
- Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome
Cochrane Systematic Reviews, 30-Jan-2013
Plasma exchange and intravenous immunoglobulin, but not corticosteroids, are beneficial in Guillain-Barré syndrome (GBS). The efficacy of other pharmacological agents is unknown. This review was first published in 2011 and this update in 2013.
- Pharmacological treatments for fatigue associated with palliative care
Cochrane Systematic Reviews, 11-Jun-2015
This review updates the original review, 'Pharmacological treatments for fatigue associated with palliative care' and also incorporates the review 'Drug therapy for the management of cancer-related fatigue'.
